Multicountry Studies on the Effect of Positional Distribution of Fatty Acids at Triglyceride Backbone on Serum Lipids, Lipoprotein(a) and LDL-subclasses in Healthy Malaysian Volunteers
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 42
- 主要终点
- Changes of Ratio of total cholesterol to HDL cholesterol (TC:HDL)
研究概览
简要总结
Fats and oils are made up of >90% triacylglycerol fat molecules which consist of a glycerol backbone to which 3 esterified fatty acids are attached. The positions of fatty acid attachment are referred to by stereospecific numbers, sn -1, -2 and -3. There is existing evidence to show that vegetable oils having unsaturated fatty acids in the sn-2 position with predominantly palmitic acid (16:0) or stearic acid (18:0) in the sn-1 and sn-3 positions of fat molecules do not raise serum cholesterol levels. These observations have come to be known as or explained by the "sn-2 hypothesis". New evidence have also emerged to show that saturated fatty acids (16:0, 18:0) in the sn-1 and -3 positions reduces fat deposition in a rat model. In this proposed study, the effects on the outcome measures investigated of three test fats [namely palm olein IV64 (POP), virgin olive oil (OOO) and cocoa butter (POS)], with oleic acid primarily at the sn-2 position but differing amounts of palmitic, stearic and oleic acids at the sn-1/sn-3 positions of the triglyceride molecule, are investigated
详细描述
To investigate the effects of different dietary fats with primarily oleic acid in the sn-2 position on the cardiovascular risk profile in healthy Malaysian volunteers
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Crossover
- 盲法
- Single (Participant)
入排标准
- 年龄范围
- 20 Years 至 50 Years(Adult)
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- 未提供
排除标准
- 未提供
结局指标
主要结局
Changes of Ratio of total cholesterol to HDL cholesterol (TC:HDL)
时间窗: week 0 (baseline) and week 4
analyzed enzymatically by Siemens Advia 2400 Chemistry Analyzer
次要结局
- changes of serum Lp(a)(week 0 (baseline) and week 4)
- changes of serum HDL cholesterol(week 0 (baseline) and week 4)
- changes of Blood pressure(week 0 (baseline) and week 4)
- changes of serum non-esterified fatty acids (NEFA)(week 0 (baseline) and week 4)
- changes of Waist circumference(week 0 (baseline) and week 4)
- changes of serum LDL cholesterol(week 0 (baseline) and week 4)
- changes of serum LDL sub-fractions(week 0 (baseline) and week 4)
- Changes of body mass index (BMI)(week 0 (baseline) and week 4)
- changes of serum Triacylglycerol (TAG)(week 0 (baseline) and week 4)
